Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01642238Phase 4Completed
Phase 4, randomised trial of ticagrelor in acute coronary syndrome (ACS) (2 arms). Primary endpoint: Platelet-thrombus Formation in an ex Vivo Model of Thrombosis at 24 hours. Started Jul 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01642238.